Genocea Biosciences Inc EBIT margin
What is the EBIT margin of Genocea Biosciences Inc?
The EBIT margin of Genocea Biosciences Inc is -1,902.09%
What is the definition of EBIT margin?
EBIT margin is a profitability ratio that measures earnings of the company as a percentage of revenue without taking into account the effect of taxes and interest.
ttm (trailing twelve months)
EBIT margin measures the profitability and operational efficiency of a company. It compares the amount of money that remains after the cost of goods and all operating expenses are subtracted from net revenue to sales. EBIT margin is calculated as earnings before interest and taxes divided by net revenue.
EBIT and EBIT margin evaluate how well a business manages its operations. Interest and taxes are not operating expenses and don’t impact operating efficiency. EBIT margin is usually used to compare operational efficiency and profitability of companies within the same industry. Taxes can vary by location thus excluding them from the calculation gives a better basis for comparing different companies.
EBIT and operating income are often used interchangeably, but there is a difference between them, which can cause the numbers to give different results. The key difference is that operating income does not include non-operating income, non-operating expenses, and other income.
EBIT margin of companies in the Health Care sector on NASDAQ compared to Genocea Biosciences Inc
What does Genocea Biosciences Inc do?
Genocea's mission is to conquer cancer by developing personalized cancer immunotherapies in multiple tumor types. Our unique ATLAS™ platform comprehensively profiles each patient's T cell responses to potential targets, or antigens, on the tumor. ATLAS enables us to optimize the neoantigens for inclusion in our immunotherapies and exclude inhibitory antigens, Inhibigens™, that can exert an immunosuppressive effect. We are advancing two ATLAS-enabled programs: GEN-009, our neoantigen vaccine and GEN-011, our neoantigen-specific cell therapy using T cells derived from peripheral blood.
Companies with ebit margin similar to Genocea Biosciences Inc
- Field Trip Health has EBIT margin of -1,986.17%
- Birla Tyres has EBIT margin of -1,964.48%
- Adamis Pharmaceuticals has EBIT margin of -1,957.91%
- Oncternal Therapeutics has EBIT margin of -1,948.70%
- Serve Robotics Inc has EBIT margin of -1,938.49%
- AC Immune SA has EBIT margin of -1,923.84%
- Genocea Biosciences Inc has EBIT margin of -1,902.09%
- Mirati Therapeutics Inc has EBIT margin of -1,899.99%
- Cyclo Therapeutics has EBIT margin of -1,831.29%
- Playgon Games has EBIT margin of -1,811.96%
- ERYTECH Pharma S.A has EBIT margin of -1,809.54%
- Celldex Therapeutics has EBIT margin of -1,809.40%
- Zoetic International Plc has EBIT margin of -1,802.73%